Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6YL4

Soluble epoxide hydrolase in complex with 3-((R)-3-(1-hydroxyureido)but-1-yn-1-yl)-N-((S)-3-phenyl-3-(4-trifluoromethoxy)phenyl)propyl)benzamide

Summary for 6YL4
Entry DOI10.2210/pdb6yl4/pdb
DescriptorBifunctional epoxide hydrolase 2, 3-[(3~{R})-3-[aminocarbonyl(oxidanyl)amino]but-1-ynyl]-~{N}-[(3~{S})-3-phenyl-3-[4-(trifluoromethyloxy)phenyl]propyl]benzamide (3 entities in total)
Functional Keywordsinhibitor, complex, seh, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight40174.05
Authors
Kramer, J.S.,Pogoryelov, D.,Hiesinger, K.,Proschak, E. (deposition date: 2020-04-06, release date: 2020-10-21, Last modification date: 2024-05-15)
Primary citationHiesinger, K.,Kramer, J.S.,Beyer, S.,Eckes, T.,Brunst, S.,Flauaus, C.,Wittmann, S.K.,Weizel, L.,Kaiser, A.,Kretschmer, S.B.M.,George, S.,Angioni, C.,Heering, J.,Geisslinger, G.,Schubert-Zsilavecz, M.,Schmidtko, A.,Pogoryelov, D.,Pfeilschifter, J.,Hofmann, B.,Steinhilber, D.,Schwalm, S.,Proschak, E.
Design, Synthesis, and Structure-Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase.
J.Med.Chem., 63:11498-11521, 2020
Cited by
PubMed Abstract: Inhibition of multiple enzymes of the arachidonic acid cascade leads to synergistic anti-inflammatory effects. Merging of 5-lipoxygenase (5-LOX) and soluble epoxide hydrolase (sEH) pharmacophores led to the discovery of a dual 5-LOX/sEH inhibitor, which was subsequently optimized in terms of potency toward both targets and metabolic stability. The optimized lead structure displayed cellular activity in human polymorphonuclear leukocytes, oral bioavailability, and target engagement in vivo and demonstrated profound anti-inflammatory and anti-fibrotic efficiency in a kidney injury model caused by unilateral ureteral obstruction in mice. These results pave the way for investigating the therapeutic potential of dual 5-LOX/sEH inhibitors in other inflammation- and fibrosis-related disease models.
PubMed: 33044073
DOI: 10.1021/acs.jmedchem.0c00561
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.001 Å)
Structure validation

249697

PDB entries from 2026-02-25

PDB statisticsPDBj update infoContact PDBjnumon